Company Profile
Lipocine Inc. Stock Price, News & Analysis
- Ticker:
- LPCN
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Lipocine is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
2.53 USD (+10.48%)
Close
Last updated: June 23, 2026 at 00:00
20.86M USD
Market cap
Why the stock is moving
LPCN is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Lipocine is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Lipocine is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Lipocine follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Lipocine sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
Lipocine to Present at A.G.P.'s Annual Virtual Healthcare Company Showcase
Source: Lipocine Inc.
- 04
Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026
Source: Lipocine Inc.
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Lipocine Inc. (LPCN)?
Lipocine Inc. (LPCN) most recently closed at 2.53 USD, a +10.48% move versus the previous session.
What is the market cap of Lipocine Inc. (LPCN)?
Lipocine Inc. currently has a market capitalization of 20.86M USD on BioPharmSignal.
What does Lipocine Inc. do?
Lipocine is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is LPCN stock listed?
Lipocine Inc. (LPCN) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Lipocine is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Lipocine?
Lipocine is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Lipocine Inc. targeting with Lipocine?
Lipocine is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.